A Genome-Wide Systematic Analysis Reveals Different and Predictive Proliferation Expression Signatures of Cancerous vs. Non-Cancerous Cells

PLoS Genetics

Volumn 9, Issue 9, 2013, Pages

  Waldman, Yedael Y ^a   Geiger, Tamar ^a   Ruppin, Eytan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RIBOSOME PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION INDEX; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS SPECIES; DNA REPLICATION; DNA SPLICING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC SCREENING; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MICROORGANISM; NON CANCEROUS PROLIFERATION INDEX; NONCANCER CELL; NONHUMAN; PREDICTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RATING SCALE; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SPECIES; SPLICEOSOME; STATISTICAL SIGNIFICANCE; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; NEOPLASMS; TRANSCRIPTOME;

EID: 84884691114     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003806     Document Type: Article

References (64)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer 127: 2893-2917.
2. Evan GI, Vousden KH, (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348.
3. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674.
4. Kittler R, Pelletier L, Heninger AK, Slabicki M, Theis M, et al. (2007) Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol 9: 1401-1412.
5. Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, et al. (2008) Cancer proliferation gene discovery through functional genomics. Science 319: 620-624.
6. Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, et al. (2008) Highly parallel identification of essential genes in cancer cells. Proceedings of the National Academy of Sciences 105: 20380-20385.
7. Marcotte R, Brown KR, Suarez F, Sayad A, Karamboulas K, et al. (2012) Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discovery 2: 172-189.
8. Mohr S, Bakal C, Perrimon N, (2010) Genomic screening with RNAi: Results and challenges. Annu Rev Biochem 79: 37-64.
9. Perrimon N, Mathey-Prevot B, (2007) Applications of high-throughput RNA interference screens to problems in cell and developmental biology. Genetics 175: 7-16.
10. Sharma S, Rao A, (2009) RNAi screening: Tips and techniques. Nat Immunol 10: 799-804.
11. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
12. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
13. Markert E, Levine A, Vazquez A, (2012) Proliferation and tissue remodeling in cancer: The hallmarks revisited. Cell Death & Disease 3: e397.
14. Shoemaker RH, (2006) The NCI60 human tumour cell line anticancer drug screen. Nature Reviews Cancer 6: 813-823.
15. Brauer MJ, Huttenhower C, Airoldi EM, Rosenstein R, Matese JC, et al. (2008) Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast. Mol Biol Cell 19: 352-367.
16. Zhao M, Sun J, Zhao Z, (2013) TSGene: A web resource for tumor suppressor genes. Nucleic Acids Res 41: D970-D976.
17. Solimini NL, Xu Q, Mermel CH, Liang AC, Schlabach MR, et al. (2012) Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 337: 104-109.
18. Higgins ME, Claremont M, Major JE, Sander C, Lash AE, (2007) CancerGenes: A gene selection resource for cancer genome projects. Nucleic Acids Res 35: D721-D726.
19. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: Tool for the unification of biology. Nat Genet 25: 25-29.
20. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, et al. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proceedings of the National Academy of Sciences 104: 1777-1782.
21. Srebrow A, Kornblihtt AR, (2006) The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
22. Venables JP, (2004) Aberrant and alternative splicing in cancer. Cancer Res 64: 7647-7654.
23. Giese A, Loo MA, Tran N, Haskett D, Coons SW, et al. (1998) Dichotomy of astrocytoma migration and proliferation. International journal of cancer 67: 275-282.
24. Giese A, Bjerkvig R, Berens M, Westphal M, (2003) Cost of migration: Invasion of malignant gliomas and implications for treatment. Journal of clinical oncology 21: 1624-1636.
25. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, et al. (2010) MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37: 620-632.
26. Höring E, Harter PN, Seznec J, Schittenhelm J, Bühring HJ, et al. (2012) The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol pp. 1-15.
27. Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, et al. (2012) Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 72: 5712-5720.
28. Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B, (2007) Functional atlas of the integrin adhesome. Nat Cell Biol 9: 858-867.
29. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, et al. (2008) Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nat Cell Biol 10: 1027-1038.
30. van Duijnhoven FJB, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, et al. (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the european prospective investigation into cancer and nutrition. Gut 60: 1094-1102.
31. Choy E, Yelensky R, Bonakdar S, Plenge RM, Saxena R, et al. (2008) Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines. PLoS genetics 4: e1000287.
32. Mizrachy-Schwartz S, Kravchenko-Balasha N, Ben-Bassat H, Klein S, Levitzki A, (2007) Optimization of energy-consuming pathways towards rapid growth in HPV-transformed cells. PLoS One 2: e628.
33. Van De Vijver, Marc J, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
34. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proceedings of the National Academy of Sciences 98: 13784-13789.
35. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, et al. (2003) Classification of human astrocytic gliomas on the basis of gene expression A correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63: 6613-6625.
36. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, et al. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer cell 3: 185-197.
37. Venet D, Dumont JE, Detours V, (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS computational biology 7: e1002240.
38. Dai H, van't Veer L, Lamb J, He YD, Mao M, et al. (2005) A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 65: 4059-4066.
39. Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, et al. (2013) Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol 14: R34.
40. Dressaire C, Redon E, Milhem H, Besse P, Loubière P, et al. (2008) Growth rate regulated genes and their wide involvement in the lactococcus lactis stress responses. BMC Genomics 9: 343.
41. Ben-Jacob E, S Coffey D, Levine H, (2012) Bacterial survival strategies suggest rethinking cancer cooperativity. Trends Microbiol 20: 403-410.
42. Im HK, Gamazon ER, Stark AL, Huang RS, Cox NJ, et al. (2012) Mixed effects modeling of proliferation rates in cell-based models: Consequence for pharmacogenomics and cancer. PLoS genetics 8: e1002525.
43. Hagner PR, Schneider A, Gartenhaus RB, (2010) Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 115: 2127-2135.
44. Meric F, Hunt KK, (2002) Translation initiation in cancer: A novel target for therapy. Molecular Cancer Therapeutics 1: 971-979.
45. Robert F, Carrier M, Rawe S, Chen S, Lowe S, et al. (2009) Altering chemosensitivity by modulating translation elongation. PLoS One 4: e5428.
46. Ruggero D, (2012) Revisiting the nucleolus: From marker to dynamic integrator of cancer signaling. Science Signalling 5: pe38.
47. Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, et al. (2012) Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 22: 51-65.
48. Van Alphen R, Wiemer E, Burger H, Eskens F, (2008) The spliceosome as target for anticancer treatment. Br J Cancer 100: 228-232.
49. Edgar R, Domrachev M, Lash AE, (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
50. Lee JK, Havaleshko DM, Cho HJ, Weinstein JN, Kaldjian EP, et al. (2007) A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proceedings of the National Academy of Sciences 104: 13086-13091.
51. Westra H, Jansen RC, Fehrmann RS, te Meerman GJ, van Heel D, et al. (2011) MixupMapper: Correcting sample mix-ups in genome-wide datasets increases power to detect small genetic effects. Bioinformatics 27: 2104-2111.
52. Östlund G, Schmitt T, Forslund K, Köstler T, Messina DN, et al. (2010) InParanoid 7: New algorithms and tools for eukaryotic orthology analysis. Nucleic Acids Res 38: D196-D203.
53. Huang D, Sherman BT, Lempicki RA, (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4: 44-57.
54. Tibshirani R, (1996) Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society.Series B (Methodological) pp. 267-288.
55. Bland JM, Altman DG, (2004) Statistics notes: The logrank test. BMJ: British Medical Journal 328: 1073.
56. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
57. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
58. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer cell 9: 157-173.
59. Chuang H, Rassenti L, Salcedo M, Licon K, Kohlmann A, et al. (2012) Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. Blood 120: 2639-2649.
60. Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, et al. (2013) Biomarker discovery in Non-Small cell lung cancer: Integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clinical Cancer Research 19: 194-204.
61. Kim DU, Hayles J, Kim D, Wood V, Park HO, et al. (2010) Analysis of a genome-wide set of gene deletions in the fission yeast schizosaccharomyces pombe. Nat Biotechnol 28: 617-623.
62. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906.
63. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2011) Database resources of the national center for biotechnology information. Nucleic Acids Res 39: D38-D51.
64. Waldman YY, Tuller T, Shlomi T, Sharan R, Ruppin E, (2010) Translation efficiency in humans: Tissue specificity, global optimization and differences between developmental stages. Nucleic Acids Res 38: 2964-2974.